Antidepressants’ Revised Med Guides Is A Step Backward – Rep. Ferguson
Executive Summary
A United States Congressman wants FDA to revert back to language that was contained in previous medication guides regarding antidepressant agents and the risk of suicide in children
You may also be interested in...
Class Labeling For Anti-epileptics Embraces Lessons From Antidepressants
Anti-epileptic drug sponsors have until mid-January to decide whether to fight FDA-mandated labeling changes and a REMS program after a meta-analysis showed a statistically significant increase in suicidality.
Class Labeling For Anti-epileptics Embraces Lessons From Antidepressants
Anti-epileptic drug sponsors have until mid-January to decide whether to fight FDA-mandated labeling changes and a REMS program after a meta-analysis showed a statistically significant increase in suicidality.
Waking Up To REMS: Sponsors Should Test Risk Management In Phase III
With Risk Evaluation and Mitigation Strategies supplanting Risk Minimization Action Plans, drug sponsors would be well served to begin preparing for negotiations over risk management plans during product development